Practice Management News

Patients with chronic pain showed greater support for several policies expanding access to cannabis compared with physicians, a research letter in JAMA Network Open showed.

Fatal and nonfatal drug overdoses experienced “unprecedented” decreases of 10% to 20% from last year, which could be due to factors like increased naloxone availability, according to researchers.

Selling a medical practice is a complex transaction that involves not only the assets of the practice itself but also implicates associated real estate.

The CDC issued a warning to health care officials, clinicians and patients about a potential risk for overdose among people ordering counterfeit prescription medications from online pharmacies.

Obscured by the celebratory congratulations and profuse praise of the scientific advance marked by the FDA’s approval of KarXT, now branded Cobenfy, is the revealing and instructive story of how this novel therapeutic agent came to fruition.

The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said.

A common question we receive every 4 years is: How will the election impact my investments?

LGBTQ+ people may be more likely to experience adverse brain health outcomes, including late-life depression and dementia, compared with cisgender straight people, according to study results published in Neurology.

Medical marijuana use led to improvements in health-related quality of life among adults referred for medical marijuana by a physician to treat qualifying medical conditions, according to a study published in Journal of Cannabis Research.

The FDA has approved Cobenfy, formerly known as KarXT, a muscarinic acetylcholine receptor agonist for the treatment of schizophrenia in adults.